S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Health and Healthcare

Oracle Buys Drug Trial Software Firm (ORCL)

Photo of Paul Ausick
By Paul Ausick Published
Follow 24/7 Wall St. on Google
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Oracle Corp. (NASDAQ: ORCL) has announced that it will acquire ClearTrial, a maker of cloud-based Clinical Trial Operations applications for an undisclosed sum. The transaction is expected to close in the first half of this year. The companies will continue to operate separately until the transaction is closed according to the Oracle announcement.

ClearTrial’s clinical trial applications “will add leading budgeting, forecasting, and analytics capabilities that help plan, source, and track clinical projects,” according to an Oracle overview of the transaction. Oracle plans to integrate ClearTrial’s solutions into its Health Sciences applications portfolio.

Oracle shares are trading down fractionally at $29.34 in a 52-week range of $24.72-$36.50.

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Douglas A. McIntyre |

Pre-Market Stock News (MAR 21, 2007)

(ABN) ABN AMRO could get late stage bids from rivals according to WSJ.(ADBE) Adobe traded up 5% after beating earnings…
Can the 800% Gain in Immuron Be Rationalized Very Easily?
Jon C. Ogg |

Can the 800% Gain in Immuron Be Rationalized Very Easily?

The day traders are back at it, chasing stocks on news with very few thoughts about what the fundamentals may…
What This FDA Update Means for Equillium’s COVID-19 Study
Chris Lange |

What This FDA Update Means for Equillium’s COVID-19 Study

Equillium shares jumped on Friday after the company announced a key update from the FDA regarding its late-stage COVID-19 trial.
Massive Biopharma Movers of the Past Week
Chris Lange |

Massive Biopharma Movers of the Past Week

A few biopharma stocks made massive runs over the course of this past week, some losing more than half their…
Is the FDA’s Hold on Inovio’s COVID-19 Vaccine Study Too Much?
Chris Lange |

Is the FDA’s Hold on Inovio’s COVID-19 Vaccine Study Too Much?

Things aren’t looking up for Inovio Pharmaceuticals, after the FDA notified the company that it was placing a partial hold…
Chris Lange |

5 Big FDA Decisions Expected in September

24/7 Wall St. has collected several big FDA decisions coming up on the calendar for the month of September and…
BioCryst Pharmaceuticals Announces Secondary Offering
Chris Lange |

BioCryst Pharmaceuticals Announces Secondary Offering

BioCryst Pharmaceuticals watched its shares fall handily on Tuesday after the firm announced a secondary offering.
4 Companies That Destroyed Shareholders Despite a Brexit Recovery
Chris Lange |

4 Companies That Destroyed Shareholders Despite a Brexit Recovery

Despite Brexit absolutely rocking the market over a week ago, the broad markets made a solid comeback leading most people to…
Chris Lange |

Why CVS Is Getting Target Pharmacies on the Cheap

Target has long been a staple for retail stores within the United States. Now CVS Health is getting a piece…

Top Gaining Stocks

Cboe Global Markets
CBOE • Vol: 1,568,143
New Pluto Global
PSKY • Vol: 12,285,993
Seagate Technology
STX • Vol: 7,378,346
Oracle
ORCL • Vol: 26,317,675
Datadog
DDOG • Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ • Vol: 4,367,433
Clorox
CLX • Vol: 13,260,523
Stryker
SYK • Vol: 4,519,455
Mohawk Industries
MHK • Vol: 1,859,865
Amgen
AMGN • Vol: 3,818,618